The researchers collected latex from wild-growing plants near their institution by snapping stems and gathering the dripping sap drop by drop. They then split the latex into five solvent extracts using acetone, methanol, ethanol, isopropyl alcohol and isoamyl alcohol, each mixed with water in an 8:2 ratio. The choice of solvent matters enormously, because polarity determines which phytochemicals dissolve out of the raw sap. After vortexing, overnight incubation and centrifugation at 10,000 rpm, the team had five distinct fractions, labeled CAE, CME, CEE, CIPE and CIAE, ready for chemical fingerprinting and biological testing.

Fourier-transform infrared spectroscopy and fluorescence spectroscopy provided the first look at what each extract contained. The FT-IR spectra revealed a broad band between 3400 and 3200 cm−1 in every extract, a signature of hydroxyl groups that pointed to the presence of phenolic compounds. All extracts except the acetone fraction showed a distinct band near 2800 to 2900 cm−1 from alkane C–H stretching, and the complex fingerprint region below 1500 cm−1 differed across solvents. Fluorescence spectra showed a distinct emission peak near 500 nm in every extract, consistent with polyphenolic compounds such as anthocyanins, phenolics, alkaloids and aromatic benzenoids, confirming that the latex is loaded with fluorescent secondary metabolites.

Quantitative assays then measured exactly how much of each phytochemical class each solvent had pulled out. The ethanol extract, CEE, was the clear winner, delivering the highest phenolic content at 0.59 mg gallic acid equivalents per milliliter, the highest flavonoid content at 0.18 mg rutin equivalents per milliliter, and the highest tannin content at 3.8 mg tannic acid equivalents per milliliter. The pattern followed solvent polarity: the most polar solvent extracted the most polar phytochemicals most efficiently, while the less polar acetone pulled out fewer. This solvent-dependence echoes earlier findings in plants such as Limonium delicatulum and Azanza garckeana, where alcohol-based extraction consistently outperformed less polar alternatives for polyphenol recovery.

Gas chromatography with a flame ionization detector then catalogued the volatile bioactive compounds in each fraction. The ethanol extract yielded the most peaks, with 29 phytocompounds detected, followed by the isoamyl alcohol extract with 23. In the acetone extract, which contained 14 peaks, the dominant compound was phytol at 43.61 percent abundance, followed by ethion at 18.67 percent and diisobutyl phthalate at 11.68 percent. Benzhydrazide emerged as a prominent compound across fractions, ranging from 5.31 percent in methanol to 67.5 percent in isoamyl alcohol, while phytol reached 64 percent in the isopropyl fraction. Several of these molecules carry documented pharmacological credentials: phytol and its derivatives have been linked to antioxidant, neuroprotective, antibacterial, anticancer and anti-inflammatory effects, while 2-phenylindole derivatives show antiviral, analgesic and anti-parasitic activities.

The antioxidant performance of the extracts was striking. Using three complementary assays, the team measured IC50 values for nitric oxide scavenging, hydroxyl radical scavenging and iron chelating activity. The ethanol extract again led the pack, with IC50 values of 14 µg/ml for nitric oxide scavenging, 15 µg/ml for hydroxyl radical scavenging and 117 µg/ml for iron chelation, all far below the corresponding values for the ascorbic acid standard, which came in at 115.23, 523.22 and 456.21 µg/ml respectively. Correlation analysis reinforced the link between chemistry and function: the R² value between total flavonoid content and nitric oxide scavenging in the ethanol extract was 0.94, while phenolic content and iron chelation correlated at 0.95, and tannin content tracked hydroxyl radical scavenging at 0.94.

Anti-inflammatory activity was assessed through a protein denaturation assay, a widely used in vitro proxy in which bovine serum albumin is heat-denatured and the protective effect of test compounds is measured by tryptophan fluorescence. Every extract showed substantial protection, but the acetone extract stood out. Adding CAE to the BSA solution dropped fluorescence intensity from 3.6 × 10⁴ INT units to 0.1 × 10⁴ INT units, and the extracts outperformed the synthetic anti-inflammatory drugs paracetamol, dexona and combiflame used as positive controls. The authors attribute this protection to complex mixtures of polyphenolics that may act cooperatively to stabilize protein structure against thermal denaturation.

The computational phase of the study focused on the three most abundant compounds in the acetone extract: phytol, ethion and diisobutyl phthalate. Using the CB-Dock2 platform, the team docked these ligands against the crystal structures of inducible nitric oxide synthase (PDB 3E7G, 2.20 Å resolution) and cyclooxygenase-2 (PDB 1CX2, 3.00 Å resolution), the two enzymes most closely associated with inflammatory signaling. Redocking a co-crystallized inhibitor into HSP90 produced an RMSD of 0.102, validating the docking protocol. The results were remarkable: diisobutyl phthalate scored −8.3 kcal/mol against iNOS, matching the −8.3 score of the standard drug combiflame, and scored −7.5 against COX-2, close to combiflame’s −7.8. Phytol followed with −7.1 against iNOS and −6.7 against COX-2, while ethion scored −5.1 and −5.6 respectively.

The interaction analysis revealed why these plant molecules bind so well. The most stable diisobutyl phthalate–iNOS complex was held together by two hydrogen bonds, three alkyl interactions, one pi-alkyl interaction and seven van der Waals contacts involving residues including Pro350, Ala351, Asn370, Leu209, Ile244, Tyr489 and Met355. Against COX-2, the same compound formed a pi-sigma interaction with Ala527, alkyl contacts with Val523 and Leu352, and five pi-alkyl interactions with residues including His90, Phe518, Trp387 and Val349. Crucially, the phytocompound occupied the same binding pose as the synthetic drug and targeted conserved residues in both active sites, with ligands docking into the oxygenase domain of iNOS and the C-terminal catalytic domain of COX-2. This dual-target engagement suggests a plausible molecular mechanism for the anti-inflammatory effects observed in the wet-lab assays.

Drug-likeness and ADMET predictions added a final layer of cautious optimism. All three compounds satisfied Lipinski’s Rule of Five, with consensus log P values between 3.56 and 6.25 indicating good oral absorption potential and predicted bioavailability scores around 0.55. Toxicity screening with ProToxII placed phytol and diisobutyl phthalate in toxicity classes 5 and 6, indicating low toxicity, and neither compound showed organ-level toxicity, though diisobutyl phthalate was flagged as active against carcinogenicity, a caveat the authors acknowledge. PASS analysis predicted anti-inflammatory activity for all three ligands with probability-of-activity scores above 0.5. The team is careful to note that these findings are preliminary: the docking scores and in vitro assays must now be validated through cell-based experiments and in vivo studies before any of these milkweed molecules can be considered genuine drug leads. Still, the convergence of chemical profiling, enzyme docking and pharmacokinetic screening paints the humble giant milkweed as a promising starting point for developing safer, plant-derived alternatives to the NSAIDs that currently dominate anti-inflammatory therapy, at the cost of gastrointestinal and cardiovascular side effects.

Subject of Research: Phytochemical profiling and molecular docking of Calotropis gigantea latex compounds against inflammatory enzymes iNOS and COX-2

Article Title: Chemical profiling and in silico analysis of phytocompounds extracted from milky-latex sap from giant milkweed Calotropis gigantea (Linn.) targeting nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) proteins

Article References: Sharma, A. D., Kaur, I., & Chauhan, A. (2026). Chemical profiling and in silico analysis of phytocompounds extracted from milky-latex sap from giant milkweed Calotropis gigantea (Linn.) targeting nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) proteins. Discover Chemistry, 3(1), Article 497. https://doi.org/10.1007/s44371-026-00951-8

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00951-8

Keywords: Calotropis gigantea, latex, phytochemicals, anti-inflammatory, iNOS, COX-2, molecular docking, GC-FID, antioxidant, phytol, diisobutyl phthalate, ADMET

The compound at the center of the study is arachidin, a prenylated stilbenoid belonging to the same chemical family as resveratrol, the celebrated polyphenol of red wine and grapes. Stilbenoids are produced by plants as defensive molecules in response to stress and pathogen attack, and arachidin and its relatives have attracted attention for their anti-inflammatory and antioxidant properties. The problem, from a practical standpoint, is that arachidin is barely detectable in ordinary peanut kernels. The Thai team solved this with plant biotechnology: peanut hairy root cultures, generated by infecting peanut tissue with the soil bacterium Agrobacterium rhizogenes, grow rapidly in liquid culture and produce abundant quantities of arachidin-3 and related stilbenoids when elicited with methyl jasmonate. A partially purified, arachidin-rich extract from these cultures became the test substance for the study.

To model the earliest stages of bile duct cancer, the researchers used MMNK-1 cells, a line of human immortalized cholangiocytes that retain the characteristics of non-malignant biliary epithelium. They exposed these cells to a cocktail of three pro-inflammatory cytokines: interleukin-6, tumor necrosis factor-alpha, and interferon-gamma. This mixture mimics the inflammatory milieu found in chronically inflamed bile ducts, where immune cells flood the tissue with signaling molecules that, over months and years, push epithelial cells toward malignancy. The cytokine treatment alone produced a striking transformation of the cells’ molecular and behavioral profile, providing a platform on which the chemopreventive potential of the arachidin-rich extract could be tested.

The first target the team examined was the STAT3 signaling pathway, a transcription factor that functions as a master switch for inflammation-associated cancer. In normal cells, STAT3 is activated only transiently, but in many tumors, including cholangiocarcinoma, it becomes constitutively phosphorylated and drives the expression of genes promoting survival, proliferation, and immune evasion. Cytokine treatment of the MMNK-1 cells induced robust STAT3 phosphorylation, and pretreatment with the arachidin-rich extract selectively suppressed this activation. The word selectively matters here: the extract dampened STAT3 signaling without wholesale toxicity to the cells, a property desirable in any candidate chemopreventive agent, which must be safe enough for long-term use in people who do not yet have cancer.

The researchers also tracked the NF-kappaB pathway, a second inflammatory signaling axis deeply implicated in biliary carcinogenesis. Cytokine exposure activated NF-kappaB, as expected, yet the arachidin-rich extract’s effects on this pathway were less pronounced than on STAT3, suggesting that the extract’s chemopreventive action is not simply a blanket shutdown of all inflammatory signaling but a more targeted interference. Alongside the signaling work, the team measured oxidative stress, quantifying intracellular reactive oxygen species with a fluorescent probe. The cytokine cocktail elevated reactive oxygen species and induced the expression of inducible nitric oxide synthase, the enzyme responsible for producing nitric oxide in inflamed tissue. Together, reactive oxygen and nitrogen species are notorious for attacking DNA, and the study confirmed that cytokine-treated cholangiocytes accumulated measurable DNA damage.

When the arachidin-rich extract was applied before cytokine exposure, the cascade of damage was blunted at multiple points. Oxidative stress fell, iNOS expression declined, and the DNA damage burden was attenuated. The functional consequences were equally significant. Cytokine-treated cholangiocytes acquired tumorigenic properties, forming colonies in anchorage-independent growth assays, a classic hallmark of cellular transformation, and they became more migratory, reflecting the acquisition of traits associated with invasion and metastasis. Pretreatment with the extract reduced colony formation and cell migration, indicating that the compound did not merely mask molecular markers but actually interfered with the acquisition of cancer-like behavior in these cells.

To probe the mechanism behind the STAT3 effect, the team turned to computational molecular docking, using the Molecular Operating Environment software to model how arachidin-3 might interact with the STAT3 protein. The docking analysis suggested a plausible binding interaction within the SH2 domain of STAT3, the region that recognizes phosphorylated tyrosine residues and is essential for STAT3 dimerization, nuclear localization, and transcriptional activity. Small molecules that occupy the SH2 domain are a recognized strategy for blocking STAT3 signaling in cancer research, and the docking results provide a structural hypothesis for how arachidin-3 might achieve the selective suppression observed in the cell experiments. The authors are careful to frame this as computational evidence, a hypothesis that will require biophysical confirmation, but it anchors the biological observations in a concrete molecular model.

The significance of the work lies in where it intervenes. Most cholangiocarcinoma research targets established tumors with cytotoxic chemotherapy, an approach that has yielded only modest survival gains. Chemoprevention, by contrast, aims to arrest the process before it begins, targeting the inflammation-driven molecular events that precede visible malignancy. In regions such as northeastern Thailand, where infection with the liver fluke Opisthorchis viverrini creates a reservoir of chronically inflamed bile ducts and cholangiocarcinoma incidence reaches among the highest levels in the world, a safe, orally available preventive agent could have enormous public health impact. The study’s use of excretory and secretory products of Opisthorchis viverrini as a reference point in the broader research context underscores the link between parasitic infection, chronic inflammation, and biliary carcinogenesis that motivates this line of work.

The authors and outside observers alike caution that the road from a cytokine-treated cell culture to a clinically validated preventive therapy is long. The current study is entirely in vitro, using immortalized rather than primary cells, and the extract, while partially purified, is a mixture rather than a single defined compound, raising questions about standardization, bioavailability, and dosing. The authors themselves emphasize the need for further in vivo and mechanistic validation, and animal models of inflammation-induced cholangiocarcinogenesis will be the logical next step before any human trial could be contemplated. There are also practical questions about scaling hairy root bioreactor production of arachidin to generate the quantities needed for preclinical toxicology and pharmacokinetic studies.

Nevertheless, the study adds a compelling entry to the growing catalogue of plant-derived chemopreventive candidates and demonstrates a rational pipeline: agricultural biotechnology to produce a scarce natural product, a disease-relevant cell model to test it, and computational structural biology to suggest a mechanism. If arachidin or a derivative survives the gauntlet of animal testing and clinical development, it would represent a new weapon against one of Asia’s most feared cancers, born not from a pharmaceutical laboratory but from the humble roots of a peanut plant coaxed into chemical overdrive in a flask. For now, the finding stands as a proof of concept that inflammation-induced cholangiocarcinogenesis can be intercepted at its molecular roots, and that the stilbenoid chemistry of plants may hold keys to doing so.

Subject of Research: Chemoprevention of inflammation-induced cholangiocarcinogenesis using an arachidin-rich extract from peanut hairy root cultures in a cytokine-treated biliary cell model

Article Title: Chemopreventive effect of arachidin-rich extract from peanut hairy root cultures on inflammation-induced cholangiocarcinogenesis in a cytokine-treated biliary cell model

Article References: Wongkham, P., Wongkham, W., Limmongkon, A., Khamto, N., Kaewkong, W., Kumphune, S., Wongkham, S., & Phimsen, S. (2026). Chemopreventive effect of arachidin-rich extract from peanut hairy root cultures on inflammation-induced cholangiocarcinogenesis in a cytokine-treated biliary cell model. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05597-8

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05597-8

Keywords: arachidin, cholangiocarcinoma, chemoprevention, STAT3, NF-kappaB, peanut hairy root cultures, cytokines, oxidative stress, iNOS, DNA damage, biliary tract cancer, molecular docking